SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-16-000953
Filing Date
2016-05-11
Accepted
2016-05-11 08:41:45
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q appy_10q-033116.htm 10-Q 446104
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 8979
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 8952
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 7724
  Complete submission text file 0001079973-16-000953.txt   2772289

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT appy-20160331.xml EX-101.INS 413686
6 XBRL TAXONOMY EXTENSION SCHEMA appy-20160331.xsd EX-101.SCH 26755
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20160331_cal.xml EX-101.CAL 42353
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20160331_def.xml EX-101.DEF 108159
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20160331_lab.xml EX-101.LAB 349095
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20160331_pre.xml EX-101.PRE 208184
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 161637930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances